Search

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

Post-COVID-19, pharma has a better opportunity than ever before to get closer to patients.

Investing in a robust, fulfilling company culture is the best way to thrive in the current challenging recruitment landscape and to achieve long-term

Demand for gene therapies is rising, so all the more reason to better understand the properties of their delivery devices

It’s time for quality and manufacturing to go paperless, but how should a company go about digitization?

The women’s health treatment landscape is devoid of relevant options. What can pharma do to improve the situation?

From surge to stumble and back again, seven cell and gene legends recount their personal favorite breakthroughs in the field.

To see continued progress, the pharma and tech industries must collaborate.

We asked the field’s greatest minds: “What improvements do we need to see in cell and gene supply chains?”

How can companies realistically incorporate patient-centric practices into cell and gene product development?